ATE375350T1 - Modulatoren von peroxisome proliferator- aktivierten rezeptoren - Google Patents

Modulatoren von peroxisome proliferator- aktivierten rezeptoren

Info

Publication number
ATE375350T1
ATE375350T1 AT03706045T AT03706045T ATE375350T1 AT E375350 T1 ATE375350 T1 AT E375350T1 AT 03706045 T AT03706045 T AT 03706045T AT 03706045 T AT03706045 T AT 03706045T AT E375350 T1 ATE375350 T1 AT E375350T1
Authority
AT
Austria
Prior art keywords
modulators
peroxisome proliferator
activated receptors
aliphatic linker
acylsulfonamide
Prior art date
Application number
AT03706045T
Other languages
English (en)
Inventor
Tracey Gibson
Nathan Mantlo
Richard Thompson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE375350T1 publication Critical patent/ATE375350T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12Radicals substituted by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT03706045T 2002-02-21 2003-02-07 Modulatoren von peroxisome proliferator- aktivierten rezeptoren ATE375350T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35942802P 2002-02-21 2002-02-21

Publications (1)

Publication Number Publication Date
ATE375350T1 true ATE375350T1 (de) 2007-10-15

Family

ID=27766083

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03706045T ATE375350T1 (de) 2002-02-21 2003-02-07 Modulatoren von peroxisome proliferator- aktivierten rezeptoren

Country Status (8)

Country Link
US (1) US20050250831A1 (de)
EP (1) EP1490058B1 (de)
JP (1) JP2005523292A (de)
AT (1) ATE375350T1 (de)
AU (1) AU2003207808A1 (de)
DE (1) DE60316780T2 (de)
ES (1) ES2292937T3 (de)
WO (1) WO2003072099A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2297382T3 (es) 2003-02-14 2008-05-01 Eli Lilly And Company Derivados de sulfonamida como moduladores de ppar.
US7262318B2 (en) * 2004-03-10 2007-08-28 Pfizer, Inc. Substituted heteroaryl- and phenylsulfamoyl compounds
US20050288340A1 (en) * 2004-06-29 2005-12-29 Pfizer Inc Substituted heteroaryl- and phenylsulfamoyl compounds
US8187727B2 (en) 2005-07-22 2012-05-29 Lg Chem, Ltd. Imidazole derivatives, preparation method thereof and organic electronic device using the same
JP5294419B2 (ja) * 2007-04-05 2013-09-18 第一三共株式会社 縮合二環式ヘテロアリール誘導体
CA2754446A1 (en) 2009-03-05 2010-09-10 Daiichi Sankyo Company, Limited Pyridine derivative
GB201617630D0 (en) 2016-10-18 2016-11-30 Cellcentric Ltd Pharmaceutical compounds
GB201806320D0 (en) 2018-04-18 2018-05-30 Cellcentric Ltd Process
BR112022010924A2 (pt) 2019-12-06 2022-09-06 Vertex Pharma Tetra-hidrofuranos substituídos como moduladores de canais de sódio
CN114901641B (zh) * 2020-02-28 2025-06-17 四川科伦博泰生物医药股份有限公司 芳香族化合物及其药物组合物和用途
SMT202500481T1 (it) 2021-06-04 2026-01-12 Vertex Pharma N-(idrossialchil(etero)aril)tetraidrofuran carbossammidi come modulatori di canali del sodio
CN118159338A (zh) 2021-08-10 2024-06-07 奇特实验室有限责任公司 用于毛发治疗的组合物、制剂和方法
US12251459B2 (en) 2022-10-12 2025-03-18 Oddity Labs, Llc Compositions, formulations, and methods for hair treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2641060A1 (de) * 1976-09-11 1978-03-16 Hoechst Ag Beta-lactamverbindungen und verfahren zu ihrer herstellung
DE2907089A1 (de) * 1979-02-23 1980-09-04 Hoechst Ag Herbizide mittel
NZ193011A (en) * 1979-03-19 1983-03-15 Ici Australia Ltd Diarylamine derivatives intermediates herbicidal compositions
EP0157225B1 (de) * 1984-03-14 1988-01-20 CASSELLA Aktiengesellschaft Verfahren zur Herstellung von Benzimidazolyl,-Benzoxazolyl- und Benzthiazolyloxyphenoxypropionsäurederivaten
FR2766822B1 (fr) * 1997-07-30 2001-02-23 Adir Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
RU2219172C2 (ru) * 1999-04-06 2003-12-20 Санкио Компани, Лимитед α-ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ КАРБОНОВЫХ КИСЛОТ
YU72201A (sh) * 1999-04-28 2005-07-19 Aventis Pharma Deutschland Gmbh. Derivati di-aril kiseline kao ppar receptorski ligandi
FR2829765A1 (fr) * 2001-09-14 2003-03-21 Lipha Derives imidazolylalkoxylarylalcanoiques leurs applications en therapeutique

Also Published As

Publication number Publication date
US20050250831A1 (en) 2005-11-10
DE60316780D1 (de) 2007-11-22
JP2005523292A (ja) 2005-08-04
AU2003207808A1 (en) 2003-09-09
WO2003072099A1 (en) 2003-09-04
DE60316780T2 (de) 2008-07-24
EP1490058B1 (de) 2007-10-10
ES2292937T3 (es) 2008-03-16
EP1490058A1 (de) 2004-12-29

Similar Documents

Publication Publication Date Title
DE60324898D1 (de) Modulatoren von peroxisome proliferator-aktivierten rezeptoren
MXPA06001274A (es) Compuestos novedosos que poseen actividad inhibitoria contra transporador dependiente de sodio.
ATE506354T1 (de) Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren
ATE375350T1 (de) Modulatoren von peroxisome proliferator- aktivierten rezeptoren
ATE434616T1 (de) Aktivator des peroxisomproliferator-aktivierten rezeptors delta
ATE374765T1 (de) Substituierte heterocyclische amide
HRP20080022T3 (en) Pyrrolopyridine derivatives and their use as crth2 antagonists
CY1107388T1 (el) Αγωνιστες αλφα υποδοχεα ενεργοποιουμενου απο πολλαπλασιαστες υπεροξυσωματων
DE60107449D1 (de) Substituierte aminopropoxyarylderivate als lxr agonisten
DK0638071T3 (da) Heterocykliske carboxylsyrederivater, der bindes til retenoidreceptorer (RAR)
DE60026318D1 (de) Isoxazolin derivate und herbizide, die diese als aktiven bestandteil enthalten
EA200300829A1 (ru) Производные 1-арил- или 1-алкилсульфонилбензазола в качестве лигандов 5-гидрокситриптамина-6
DK0605228T3 (da) Thiazolidindionderivater, deres fremstilling og anvendelse
TR200402069T4 (tr) Difenilüre türevleri ve bunların alfa 2/5-HT2c antagonisti olarak kullanılması
DE69507293D1 (de) Benzamid-derivate als vasopressin-antagonisten
HRP20090474T1 (hr) Postupak i intermedijeri za sintezu kaspofungina
ATE261941T1 (de) Heterocyclische amide als inhibitoren von faktor xa
BRPI0409465A (pt) derivados de carboxamida como agentes antidiabéticos
PA8573501A1 (es) Derivados de benzoxazina y su empleo
EA200700997A1 (ru) 2,5- и 2,6-дизамещенные аналоги бензазола, полезные в качестве ингибиторов протеинкиназ
HRP20070286T3 (en) Substituted diketopiperazines and their use as oxytocyn antagonists
ATE373636T1 (de) Amidderivate als inhibitoren der enzymatischen aktivität von renin
EA200401077A1 (ru) 2-оксазоламины и их применение в качестве антагонистов рецептора 5-ht2b
ATE348800T1 (de) 4'-methansulfonylbiphenylderivate als hochselektive cyclooxygenase-2-inhibitoren
TW200635911A (en) Sulfanyl substituted phenyl methanones

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties